The Drug Supply Chain and Security Act (DSCSA) establishes a national system for tracing prescription drugs through the supply chain and sets national licensing standards to enhance the U.S. Food and Drug Administration’s (FDA) ability to help protect consumers from suspicious drugs.
Starting November 27, 2023, health centers must obtain a Global Location Number (GLN) for each site receiving products. The GLN helps businesses know who is involved in transactions and where things are located throughout the supply chain.
Review the DSCSA factsheet here to understand how to obtain GLNs and to learn more about DSCSA.